SOX2 and colorectal carcinoma: Furthermore, we found that simultaneous activation of acetylation and inhibition of O-GlcNAcylation led to near-complete suppression of Sox2 in CRC cells, suggesting that the additive effects of these PTMs on Sox2 suppression might be used in cancer treatment.